Hólyagrák: vizsgálatok itt: Oroszország

2 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.

• No phaseTaking people
  TReatment Approaches and bIomarkers preValence in bladdEr Cancer in RuSsian Federation

  Where

  Arkhangelsk, Barnaul, Chelyabinsk, Krasnodar, Krasnoyarsk, Makhachkala, Moscow, Nizhny Novgorod, Novosibirsk, Obninsk, Omsk, Saint Petersburg, Tomsk, Tyumen, Ufa, Yekaterinburg

  Életkor

  18 év and over

  People

  600

  Run by

  AstraZeneca

  See details and how to joinNCT07038928
• 2. fázisTaking people
  Sequential Gemcitabine Plus Docetaxel Versus Gemcitabine Plus Mitomycin C for BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer

  Where

  Moscow

  Életkor

  18 év and over

  People

  228

  Run by

  Blokhin's Russian Cancer Research Center

  See details and how to joinNCT07747740